All-trans-retinoic acid is used in treatment of
**Core Concept**
All-trans-retinoic acid (ATRA) is a derivative of vitamin A that plays a crucial role in the treatment of certain types of leukemia. It works by promoting the differentiation of immature cells into mature cells, thereby reducing the risk of complications associated with these immature cells.
**Why the Correct Answer is Right**
All-trans-retinoic acid is specifically used in the treatment of acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML). APL is characterized by the accumulation of immature granulocytes called promyelocytes. ATRA binds to retinoic acid receptors, which in turn activate the transcription of target genes involved in cell differentiation. This leads to the maturation of promyelocytes into mature granulocytes, thereby reducing the risk of complications such as disseminated intravascular coagulation (DIC) and bleeding. ATRA has been shown to improve survival rates and reduce the risk of relapse in patients with APL.
**Why Each Wrong Option is Incorrect**
**Option B:** A.L.L (Acute Lymphoblastic Leukemia) is a different subtype of leukemia that primarily affects lymphoid cells, not myeloid cells. ATRA is not typically used in the treatment of ALL.
**Option C:** CML (Chronic Myeloid Leukemia) is a different subtype of leukemia that affects myeloid cells, but it is primarily treated with tyrosine kinase inhibitors such as imatinib. ATRA is not a standard treatment for CML.
**Option D:** Transient myeloproliferative disorder is a condition that affects newborns and is characterized by the accumulation of immature myeloid cells. While it is a myeloproliferative disorder, ATRA is not typically used in its treatment.
**Clinical Pearl / High-Yield Fact**
ATRA is a classic example of a differentiation therapy, where a medication is used to promote the maturation of immature cells. This concept is also seen in other medications such as azacitidine and decitabine, which are used to treat other subtypes of AML.
**β Correct Answer:** A. Acute promyelocytic leukemia